Santos Ltd
F:STS1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Santos Ltd
F:STS1
|
AU |
|
B
|
Ball Corp
NYSE:BALL
|
US |
|
N
|
Nido Education Ltd
ASX:NDO
|
AU |
|
T
|
Translational Development Acquisition Corp
NASDAQ:TDAC
|
US |
|
Crescent Biopharma Inc
F:C68
|
US |
|
C
|
Cirralto Ltd
OTC:CROTF
|
AU |
|
Agung Podomoro Land Tbk PT
IDX:APLN
|
ID |
|
Vivos Therapeutics Inc
NASDAQ:VVOS
|
US |
Wall Street
Price Targets
STS1 Price Targets Summary
Santos Ltd
According to Wall Street analysts, the average 1-year price target for
STS1
is 4.387 EUR
with a low forecast of 3.529 EUR and a high forecast of 5.223 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is STS1's stock price target?
Price Target
4.387
EUR
According to Wall Street analysts, the average 1-year price target for
STS1
is 4.387 EUR
with a low forecast of 3.529 EUR and a high forecast of 5.223 EUR.
What is Santos Ltd's Revenue forecast?
Projected CAGR
10%
For the last 14 years the
compound annual growth rate for
Santos Ltd's revenue is
5%.
The projected
CAGR
for the next 3 years is
10%.
What is Santos Ltd's Operating Income forecast?
Projected CAGR
23%
For the last 14 years the
compound annual growth rate for
Santos Ltd's operating income is
4%.
The projected
CAGR
for the next 3 years is
23%.
What is Santos Ltd's Net Income forecast?
Projected CAGR
22%
For the last 14 years the
compound annual growth rate for
Santos Ltd's net income is
0%.
The projected
CAGR
for the next 3 years is
22%.
